Evaluation of Canakinumab in High-Risk Former-Smokers

Clinical trial NCT06038526 · COMPLETED

Trial details

NCT number: NCT06038526
Sponsor: Peter Shields
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cigarette Smoking-Related Carcinoma Lung Carcinoma

Start date: 2024-03-11
Primary completion: 2026-02-04
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.